Table 21.
Sixteen-Year Total Deaths, and Median Survival in Months with 95% Confidence Intervals for Primary Malignant Brain and Other CNS Tumor Histologies, CBTRUS Statistical Report: NPCR, 2001-2016
| Histology | N | Deaths | Median survival (95% CI) |
|---|---|---|---|
| Pilocytic Astrocytoma | 12,068 | 822 | ** (** -**) |
| Diffuse Astrocytoma | 18,420 | 9,662 | 36 (34-38) |
| Anaplastic Astrocytoma | 13,643 | 9,509 | 18 (17-18) |
| Unique Astrocytoma Variants | 1,564 | 637 | 44 (36-54) |
| Glioblastoma | 113,412 | 103,642 | 8 (8-9) |
| Oligodendroglioma | 9,062 | 2,362 | 119 (115-124) |
| Anaplastic Oligodendroglioma | 3,943 | 1,723 | 60 (57-64) |
| Oligoastrocytic Tumors | 6,087 | 2,618 | 71 (68-76) |
| Ependymal Tumors | 9,344 | 1,831 | ** (155-**) |
| Glioma Malignant, NOS | 16,323 | 7,403 | 37 (34-42) |
| Choroid Plexus Tumors | 310 | 114 | 77 (57-107) |
| Other Neuroepithelial Tumors | 151 | 46 | 88 (52-**) |
| Neuronal and Mixed Neuronal Glial Tumors | 1,907 | 573 | 93 (85-109) |
| Tumors of the Pineal Region | 888 | 295 | 75 (68-102) |
| Embryonal Tumors | 8,422 | 3,201 | 66 (61-73) |
| Nerve Sheath Tumors | 467 | 174 | 95 (68-135) |
| Meningioma | 3,807 | 1,771 | 53 (48-58) |
| Mesenchymal Tumors | 845 | 337 | 72 (56-85) |
| Primary Melanocytic Lesions | 140 | 105 | 11 (7-17) |
| Other Neoplasms Related to the Meninges | 579 | 190 | 83 (70-99) |
| Lymphoma | 15,057 | 10,109 | 13 (13-14) |
| Other Hemopoietic Neoplasms | 392 | 138 | 84 (49-140) |
| Germ Cell Tumors, Cysts and Heterotopias | 2,442 | 327 | ** (** -**) |
| Tumors of the Pituitary | 343 | 102 | 139 (113-**) |
| All Other | 72 | 23 | 133 (35-**) |
| Neoplasm Unspecified | 8,596 | 7,083 | 2 (2-2) |
** cannot be calculated
Abbreviations: CBTRUS, Central Brain Tumor Registry of the United States; NPCR, National Program of Cancer Registries; CI, confidence interval; NOS, not otherwise specified